Studies linking AD and neurovascular function have focused on fibrinogen [88], imaging biomarkers of amyloid-beta and neurodegeneration (e.g., plasma neuronal-enriched extracellular vesicles), MRI, amyloid PET, tau PET, and fluorodeoxyglucose PET (reviewed in [89–92]). This evidence concerns the gene MAPT and Alzheimer disease.